Daniel was a presenter at the Innovation in Quantitative Medicine Summit. convened by the FDA and Duke to inform the establishment of the Quantitative Medicine Innovation Network (QMIN). The QMIN will bring together academic institutions, industry sponsors, contract research organizations, regulators, and patient advocates in a sustained, cross-sector collaboration to advance the science and regulatory application of quantitative medicine with the goal of fundamentally transforming drug development and clinical care.